- Report
- August 2024
- 175 Pages
Global
From €4753EUR$5,000USD£3,993GBP
- Report
- April 2024
- 30 Pages
Global
From €3090EUR$3,250USD£2,596GBP
- Report
- October 2024
- 195 Pages
Global
From €3370EUR$3,545USD£2,831GBP
€3745EUR$3,939USD£3,146GBP
- Report
- February 2025
- 162 Pages
Global
From €5181EUR$5,450USD£4,353GBP
- Report
- May 2024
- 137 Pages
Global
From €6178EUR$6,499USD£5,190GBP
- Report
- May 2024
- 128 Pages
Global
From €6178EUR$6,499USD£5,190GBP
- Report
- May 2024
- 135 Pages
Global
From €6178EUR$6,499USD£5,190GBP
- Report
- May 2024
- 130 Pages
Global
From €6178EUR$6,499USD£5,190GBP
- Report
- May 2024
- 140 Pages
Global
From €6178EUR$6,499USD£5,190GBP
- Report
- May 2024
- 138 Pages
Global
From €6178EUR$6,499USD£5,190GBP
- Report
- May 2024
- 133 Pages
Global
From €6178EUR$6,499USD£5,190GBP
- Report
- May 2024
- 140 Pages
Global
From €6178EUR$6,499USD£5,190GBP
- Drug Pipelines
- April 2024
- 180 Pages
Global
From €2852EUR$3,000USD£2,396GBP
- Clinical Trials
- April 2024
- 80 Pages
Global
From €1426EUR$1,500USD£1,198GBP
- Report
- April 2018
- 470 Pages
Global
From €2852EUR$3,000USD£2,396GBP
- Report
- September 2023
- 100 Pages
Global
From €5656EUR$5,950USD£4,752GBP
- Report
- February 2024
- 129 Pages
Global
From €4040EUR$4,250USD£3,394GBP
- Report
- January 2022
- 119 Pages
Global
From €4230EUR$4,450USD£3,554GBP
- Report
- February 2024
- 110 Pages
Global
From €4516EUR$4,750USD£3,794GBP
- Report
- June 2022
- 114 Pages
Global
From €4516EUR$4,750USD£3,794GBP

Keytruda is a type of skin cancer drug used to treat melanoma, a type of skin cancer. It is a type of immunotherapy, which works by helping the body’s immune system recognize and attack cancer cells. Keytruda is a monoclonal antibody, which means it is designed to target a specific protein on the surface of cancer cells. It is approved for use in adults and children with advanced melanoma, and is also being studied for use in other types of cancer.
Keytruda is one of several skin cancer drugs on the market. Other drugs used to treat melanoma include Yervoy, Opdivo, and Tecentriq. These drugs are all immunotherapies, and work in different ways to help the body fight cancer.
Companies in the Keytruda market include Merck, which manufactures the drug, as well as Bristol-Myers Squibb, Roche, and AstraZeneca. These companies are all involved in the research, development, and marketing of Keytruda and other skin cancer drugs. Show Less Read more